KROS SG&A Expenses
Keros Therapeutics Inc · SG&A Expenses
KROS SG&A Expenses
Latest reported$40.62Mperiod ending
KROS SG&A Expenses ($1.58M → $40.62M)
Annual SG&A Expenses
High-resolution chart · PNG
KROS sg&a expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 46,849,000 | |
| 40,754,000 | |
| 34,834,000 | |
| 27,525,000 | |
| 21,330,000 | |
| 12,192,000 | |
| 3,184,000 | |
| 1,580,000 |